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Detection of low grade mosaicism in Turner syndrome using fluorescence in-situ 
hybridization (FISH) 
Turner syndrome is a common sex chromosomal abnormality, typically presenting with 
premature gonadal dysgenesis and short stature. This phenotype is due to the absence of 
X-chromosome (45,X) in some or all cells; or due to the presence of structurally 
abnormal X-chromosome resulting in the haploinsufficiency of X-Y homologous loci 
which escape X-inactivation. Sometimes, although the resulting phenotype is similar to 
those with 45,X (Hassold et al.,1988), the diagnosis of 46,XX karyotype invalidates the 
attempts of genotype-phenotype correlations (Ferguson-Smith,1965), which could be due 
to the presence of low grade mosaicism undetected by the standard cytogenetic 
techniques. Vice versa, the high in-utero lethality of 45,X condition has led to the 
hypothesis that most of the live born 45,X individuals have low frequency of normal cells 
which might be necessary for survival.  
 
The aims of this study were to detect the presence of low levels of monosomic X cells in 
karyotypically normal patients (study group I) presenting with Turner stigmata (n=11), to 
detect the percentage of normal 46,XX cells in karyotypically proven Turner patients 
(study group II)  (n=17), and to investigate a control group (group III) of  normal women 
(n=25). Based on the levels of monosomy X cells in the control group, baseline value 
was established and values exceeding this could then be classified as low grade 
mosaicism. This was achieved using the fluorescence in- situ hybridization (FISH) 
technique in addition to the standard cytogenetic techniques.                                                                            
 vi
Results showed a low percentage of abnormal X cells (45,X and 47,XXX) in the first 
group of patients ranging from 0.1%-2.74% (Mean: 1.31%, SD 1.03), which was 
significantly higher than that observed in the normals (p=0.003, Mann-Whitney U test). 
Using the ROC curve, a baseline cut-off value of 0.897% was obtained with a sensitivity 
of 63.6% and a specificity of 100%.The results showed that the recommended cut-off 
value was 1% which was obtained by rounding off the cut-off value obtained from the 
ROC curve analysis. 
Eighty-eight percent (15 out of 17) of the second group of patients (karyotypically proven 
Turner patients) showed normal 46,XX cells ranging from 0-95% with G-banding and 
FISH. The remaining 12% (2 out of 17) showed a low percent ranging from 0.06% to 
0.1% of 46, XX cells only with FISH technique. Two cases remained apparent 45,X 
Turner with G-banding, which may be explained by tissue-confined mosaicism 
(Held,1993) necessitating the need to analyze cells from a different germ line or may be a 
consequence of a selective loss of a second cell line during embryonic development (Held 
et al., 1992). 
FISH appeared to be a more sensitive technique compared to the conventional methods in 
detecting low grade mosaicism and hence the use of FISH technique is suggested in such 
patients to enhance the diagnosis and enable genotype-phenotype correlation. 
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Turner syndrome (45,X) is a common sex chromosomal abnormality with an incidence of 
about 1 in 2500 liveborn female babies.  Individuals with Turner Syndrome are 
phenotypically females with gonadal dysgenesis and somatic stigmata, like short stature, 
but have normal intelligence. This phenotype is due to the absence of the X-chromosome 
(45,X) in some or all cells; or due to the presence of a structurally abnormal X-
chromosome, resulting in the haploinsufficiency of X-Y homologous loci, which escape X-
inactivation. It is estimated that 40-50% of patients with Turner syndrome demonstrate sex 
chromosome mosaicism (45,X/46,XX) (Magenis et al., 1980). Although the resulting 
phenotype is similar to those with 45,X sometimes (Hassold et al., 1988), the diagnosis of 
46,XX karyotype by conventional cytogenetic technique invalidates the attempts of 
genotype-phenotype correlations (Ferguson-Smith, 1965). This is most probably due to the 
inability to detect low-grade mosaicism. Detection of low-grade mosaicism involves many 
factors, like the type and number of tissues analyzed, the number of cells studied and the 
sensitivity of the techniques applied (Hook, 1977; Procter et al., 1984; Held et al., 1992; 
Jacobs et al., 1997). Hence, in this study the fluorescence in-situ hybridization technique 
(FISH) was used in addition to the conventional cytogenetic methods, to detect the low 
percentage of abnormal cell lines in patients with Turner stigmata, but with a normal 
karyotype.  
 
Vice-versa, the high in-utero lethality of the 45,X condition has led to the hypothesis that 
most of the live born 45,X individuals may have a low frequency of normal cells (46,XX), 
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which might be necessary for survival. Therefore, this study also included the detection of 
normal 46,XX cells in typical Turner patients with a 45,X karyotype. 
In this study, both conventional cytogenetic techniques and fluorescence in-situ 
hybridization (FISH) techniques were used to analyze the chromosomes from the 
patient’s peripheral lymphocytes. The FISH technique has an advantage over the   
conventional cytogenetic methods in detecting low-grade mosaicism, as a large number 
of cells can be counted, and both the interphase as well as the metaphase nuclei can be 
analyzed. 
 
It is known that as a consequence of aging, errors occur in cell divisions, leading to the 
loss of the inactivated X-chromosome (Surralles et al., 1999). So a low percent of 
abnormal cells could also be present in normal females. To verify whether the low-grade 
mosaicism observed is a significant cause for the phenotype, a group of age matched 
fertile females (25 controls) was also studied using the same test parameters. With these 
controls, a baseline value can be set and the values exceeding this could then be classified 
as low-grade mosaicism. 
 
In general, a mosaic level of lower than 5% is considered to be low-level mosaicism 
(Schinzel, 1974). Conventional cytogenetic analysis needs 60 cells to be scored to 
exclude a 5% mosaicism at a 0.95 confidence interval (Hook, 1977). In our study we 
scored 100 metaphases by standard G-banding. This excluded a 3% mosaicism at 95% 
confidence interval. For the detection of mosaicism less than 1%, analysis of at least 500 
metaphases is necessary to prove the presence of low percent abnormal clones. This is 
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very difficult to do with conventional cytogenetic methods. Therefore the same samples 
were analyzed by the fluorescence in-situ hybridization technique to solve this problem. 
The X chromosome was labeled with a dual probe containing the X centromere (DXZ1) 
as well as Xp terminal end (LSI STS Xp) probe. X centromeric probe (DXZ1) labeled in 
spectrum green and locus specific probes spanning the steroid sulfatase region (LSI STS 
Xp) on the Xpter labeled in spectrum orange (as an internal control) from Vysis were 
used. DAPI was used as a counterstain and slides were visualized under a fluorescence 
microscope with the appropriate filters. Evaluating 5000 cells (both metaphases and 
interphases) will exclude exclude mosaicism at 95% confidence interval. 
 





                                      
 




















2. Literature review 
2.1: Turner syndrome 
Dr.Henry Turner first described Turner syndrome in 1938 (Turner, 1938). It is a common 
sex chromosomal abnormality with an incidence of about 1 in 2500 liveborn female 
babies. Individuals with Turner syndrome display a female phenotype with typical 
features which include short stature, sexual infantilism due to rudimentary ovaries; a 
variety of somatic features will include micrognathia, prominent epicanthic folds, low set 
ears, cubitus valgus and a short and broad neck with webbing. Turner patients tend to 
have a high frequency of certain cardiovascular and renal abnormalities. The mental 
intelligence is usually normal (Lippe, 1991). This above phenotype is due to the absence 
of one X-chromosome leading to X-chromosome monosomy (45,X) in some or all cells 
or due to the presence of structurally abnormal X-chromosome resulting in the 
haploinsufficiency of X-Y homologous loci situated at the level of the pseudoautosomal 
region of the gonosomes which escape X-inactivation (Ogata et al., 1995). 
2.2: Numerical anomalies of X chromosome leading to Turner syndrome: 
2.2.1: X chromosome monosomy 
The most common karyotype in Turner syndrome is the 45,X karyotype (45 
chromosomes per cell, with only one sex chromosome) that represents 40 to 50% of cases 
(Fig 1), whereas the normal female karyotype is 46,XX (Fig 2).  
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Figure 1: Classical karyotype of Turner syndrome 
 
 
Figure 2: Normal female karyotype 
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There are two theories that try to explain this chromosomal monosomy (the loss of one of 
the sexual chromosomes). 
According to the meiotic theory, during the formation of the ovule or sperms 
(gametogenesis), some of them could have suffered an error and for this reason they carry 
one chromosome less. If the ovule or the sperm have suffered this chromosomal loss, the 
embryo formed from the fertilization will carry this chromosomal error. Monosomal 
aneuploidy is due to non-disjunction or failure of normal separation of a chromosome 
pair when the eggs or sperms are formed during meiosis. Normally the 46 chromosomes 
present in a cell are copied (replication) and paired up. The pairs of chromosomes are 
separated (segregation) during meiosis 1. During meiosis 2, a second division of the 
chromosomes occurs resulting in the formation of four sperms, or one egg and three polar 
bodies, each with 23 chromosomes. In the normal situation, the mature eggs and sperms 
are monosomic (one copy) for each chromosome. This leads to disomy (two copies of 
each chromosome) following fertilization. 
Nondisjunction can occur in meiosis 1 or meiosis 2 (Fig 3 & 4). Nondisjunction leads to 
the formation of two chromosomally different eggs or sperms; one has a pair of 
chromosomes (disomic), and the other has no chromosome (nullisomic). The former, 
when fertilized by a normal egg or sperm, with one copy of each chromosome 
(monosomic), leads to a trisomic fetus and the latter leads to a monosomic fetus.  
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Figure 4: Non-disjunction in meiosis 2 
 
In the mitotic theory, the loss of one of the chromosomes in the gametes (ovule or sperm) 
originates later, during the first period of the embryonic growth (in the first gestation 
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weeks). Anaphase lag is the mechanism where one chromosome simply fails to get 
incorporated into the nucleus of a daughter cell; or, a malfunction in chromosome sorting 
may find two identical chromosomes in the same daughter cell.  This will result in mosaic 
Turner syndrome, which is discussed in 2.2.2.  
 It has now been proven that the Turner syndrome is not necessarily due to the absence of 
entire X chromosome but is a result of haploinsufficiency of X-Y homologous loci that 
escape X-inactivation. Dosage compensation in mammals has been achieved by X-
chromosome inactivation to allow the female to have the same amount of X-chromosome 
material as the average male. Lyon hypothesized that early in the development of a 
normal female embryo, random inactivation of one of the two X-chromosomes in each 
cell occurs. This inactivation of an X chromosome requires a gene on that chromosome 
called XIST. XIST encodes a large molecule of RNA which accumulates along the X 
chromosome containing the active XIST gene and proceeds to inactivate all (or almost all) 
of the other hundreds of genes on that chromosome. XIST RNA does not cross over to 
any other X chromosome in the nucleus. Barr bodies are the inactive X chromosomes 
"painted" with XIST RNA (Bohorfoush et al., 1972). 
During the early stages of embryonic development of a normal female, the XIST locus on 
each of her two X chromosomes is expressed. Transcription continues on one of the X 
chromosomes, leading to an accumulation of XIST RNA and converting that chromosome 
into an inactive Barr body. Transcription of XIST ceases on the other X chromosome 
allowing the hundreds of other genes to be expressed. The shut-down of the XIST locus 
on the active X chromosome is done by methylating XIST regulatory sequences. DNA 
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methylation usually results in gene repression, so methylation permanently blocks XIST 
expression and permits the continued expression of all the other X-linked genes (Gartler 
et al., 1983). However, some genes on the X chromosome escape inactivation. These are 
present on the pseudoautosomal regions (PAR) of both the X and Y-chromosomes. There 
are about 18 genes that are identical on both X and Y chromosomes and these genes 
escape inactivation in females to maintain a balance with the situation in males. In 
addition, there are other genes on the X chromosome that are not regulated by X 
inactivation whose expression is thus altered in Turner syndrome as compared to normal 
females (Brown et al., 1990; Fisher et al., 1990). In this way, the normal female has 
functioning genes from one complete X-chromosome along with functioning genes from 
the inactivated X-chromosome. On the other hand, Turner syndrome females, with X-
chromosome aneuploidy lack the genes that would normally have remained active.  
2.2.2: Mosaic Turner syndrome: 
Fifteen to twenty percent of cases of Turner syndrome are cytogenetic mosaics with 45,X 
cells and clones of other cells with either 46,XX, 46,XY, 47,XXX or aberrant sex-
chromosome complements. These result in variants like 45,X/46,XX,45,X/47,XXX,  
45,X/46,XY etc (Abulhasan  et al., 1999). 
 Chromosomal mosaicism is defined as the occurrence of 2 or more cell lines with 
different chromosomal make-up in an individual, developed from a single fertilized egg.  
Turner syndrome mosaicism is an example of monosomy mosaicism specifically for the 
X chromosome where, along with the normal diploid cell line, there is another cell line 
which has only one X chromosome instead of two (Kao et al., 1991).  The cells with 
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abnormal chromosomes may be found in multiple tissues, or in just one tissue. Changes 
in the number or structure of chromosomes in different cells of the body can have 
variable impact on the proper functioning of the human body (Amiel et al., 1996). If only 
a tiny fraction of some tissues were involved, the aneuploidy would likely to have little 
effect on growth and development. However, a very minor degree of mosaicism could 
still be important if a crucial tissue carries the abnormal cells.  As a general principle, an 
individual with a chromosome mosaicism in some of his or her tissues is likely to have 
less severe but qualitatively similar clinical features to that of someone with the non-
mosaic form of the same chromosome abnormality. 
 The mosaic pattern depends on many factors.  
• Mosaicism originating from an error, either in the first or second division of the 
fertilized egg, leads to generalized mosaicism, since most tissues of the baby are 
affected, often in a "patchy" way.  
• An error that occurs at a later stage, for example at the 64-celled blastocyst stage, will 
affect a smaller proportion of the cells in the baby.  "Later errors" may lead to an 
abnormal line of cells confined to a specific area or tissue in the developing 
individual.  
Age related mosaicism: 
It is noted that 45,X cells are increasingly common in female blood cells as they age, but 
appear to have no harmful effect.  
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2.3: Structural anomalies of X chromosome: 
Twenty five percent of cases with 46,XX karyotype have a  structural alteration of one of 
the X chromosomes i.e., deletions, duplications or isochromosomes. In rare cases a ring 
X chromosome complement can be identified. Structural X chromosome abnormalities 
are not unusual and  occur as a result of breakages in the X chromosome with subsequent 
reunion of X chromosome sequences. These karyotypes include 46,X,i(Xq), 
46,X,del(Xp), 46,X,del(Xq) and 45,X/46,X,r(X). The clinician must be aware of the 
differing susceptibilities of these various karyotypes, as the phenotype may be 
attributable to the limited amount of genetic material in these abnormal chromosomes 
(Hook et al., 1983). 
2.3.1: Isochromosome Xq [46,X,i(Xq)]:  
This consists of the two long arms of the X-chromosome but no short distal arm (Fraser 
et al., 1989). It is the most common structural abnormality occurring in the Turner 
syndrome. The phenotype in these patients is similar to the phenotype of 45,X with 
perhaps an increased risk of autoimmune disorders (diabetes and thyroid disease) and is 
associated with deafness, but congenital abnormalities are conspicuously absent (Stratakis 
et al., 1994).  
2.3.2: Ring X chromosome [45,X/46,X,r(X)]: 
Intelligence is average or above average in Turner syndrome patients, except in rare cases 
of tiny ring X chromosomes. Mental retardation may be present in some cases due to the 
inability of these abnormal chromosomes to undergo X inactivation (Atkins et al, 1966; 
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Van Duke et al 1992). Recently, some cases in which the ring is small and does not 
contain the X-inactivation center have been described; the phenotype is abnormal with 
atypical Turner syndrome stigmata and severe mental retardation, possibly due to lack of 
dosage compensation (Dennis et al., 1993).  
2.3.3: Deletions of the ‘p’ or ‘q’ arms of the X chromosome i.e. 46,X,del(Xp) or 
46,X,del(Xq): 
The tip of the Xp forms the meiotic pairing region and crossing over takes place in the 
pseudoautosomal region (PAR), which always stays active on both the chromosomes 
(Burgoyne, 1983). The region adjacent to this PAR on Xp22.3 contains the SHOX gene 
important for long bone growth, deletion of which leads to short stature. The loss of 
SHOX may also explain some of the skeletal features found in Turner syndrome, such as 
short fingers and toes, and irregular rotations of the wrist and elbow joints (Morizio et al., 
2003; Ogata et al 2001). Generally loss of the entire short arm from Xp11 to Xpter leads 
to a full-blown Turner syndrome. 
The X centromere to the Xp11 region has been referred to as the active "b" region 
(Therman et al., 1990) and may contain genes for gonadal development (Simpson et al., 
1987). The region from the X centromere to Xq13, which interestingly has never been 
found to be missing, contains the XIST gene that is always active on the inactive X 
chromosome. 
In long arm deletions, Madan et al., (1981) postulated the so called critical region in the 
Xq arm, for gonadal dysgenesis consisting of two segments, Xq13-q22 and Xq22-26, 
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separated by a short region in Xq22.  Whereas loss of the Xp tip results in short stature, 
the tip of Xq has been postulated to have genes, loss of which lead to premature ovarian 
failure (Fitch et al., 1982). Surveys on various X chromosomal deletions, apart from the 
above mentioned characteristics show a surprising similarity in all the presenting 
symptoms. To explain this, a hypothesis was proposed that in Xq deleted patients the X-
inactivation spreads to tip of Xp, thus inactivating the normally active X regions, hence it 
is the extent of X inactivation that causes the symptoms and not specific breakpoints 
(Sharpe et al., 2002). 
 
Table 1: Phenotypic features of X chromosome deletions with ideogram of X 
chromosome on the right hand side 
 
      Deleted regions 
    Ovaries    Stature 
      Somatic stigmata 
    of Turner syndrome 
Short arm       
Xpter~p21 Normal Short None 
All of Xp Dysgenesis Short Most or all 
Long arm    
Xqter~q22 Dysgenesis Normal None to few 
Xqter~q13 Dysgenesis Normal None to some 
All of Xq Dysgenesis Normal Several 




2.3.4: Patients with residual Y chromosome material: 
Recent molecular studies done on peripheral blood cells have shown that some 
individuals with 45,X and even mosaic 45,X/46,XX have residual cytogenetically 
undetectable Y-chromosome material by cytogenetic methods (Muller et al., 1987; 
Koncova et al., 1993; Shankman et al., 1995). The residual Y-chromosome material may 
not be present in the peripheral blood cells (Koncova et al, 1993). Thus fibroblasts and 
gonadal cells need to be studied if mosaicism for Y-chromosome DNA sequences is 
present; these patients are at increased risk for excessive virilization and increased risk of 
gonadoblastoma.  
2.4: Clinical presentation of Turner syndrome through the different life stages: 
 Turner syndrome embraces a broad spectrum of features with almost all patients having 
ovarian dysfunction, short stature, somatic and visceral abnormalities; the severity of 
symptoms varies considerably amongst the individuals. The phenotype is complex and 
multiple (Judith et al., 1995). Female phenotype is due to the absence of Y-chromosome, 
the testis determining gene.  
The clinical and presenting features of Turner syndrome change with age and can be 
divided into stages: embryonic period, newborn period, childhood period, adolescent 
period and adulthood (Hall, 1990). 
Embryonic and fetal life: 
Nearly 10% of spontaneously aborted fetuses have a 45,X karyotype and the incidence 
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 has been estimated as 0.8% in zygotes, making it possibly the most common 
chromosomal disorder. Only 1% of human Turner zygotes survive to term. More than 95-
99% of 45,X conceptuses die during gestation (Simpson 1976, Hook et al., 1983).  
It was observed that the early mortality is much less in 46,X,i(Xq) than in 45,X cases 
suggesting that the loss of loci on Xp may be lethal (Hook et al., 1983). Although the 
period of death may extend throughout the gestation, the vast majority of 45,X 
conceptuses die in the first trimester with a mean developmental age of 6 weeks (Boue et 
al., 1976). 
Two explanations were considered for early death during gestation, which were not 
dissimilar to those regarding the lethality of autosomal aneuploidy.  
• One explanation was that most 45,X abortuses have such severe congenital defects 
that further viability is precluded (Burgoyne et al., 1983).  
• The other explanation is that the problem is not with the 45,X embryos and fetuses 
themselves but with their placentas. The aneuploid state probably interferes with the 
placental growth and function so that the placenta is unable to sustain a normally 
functioning embryo or fetus. This was suggested to be due to the compromised 
placental steroidogenesis, thereby leading to an inability to maintain an otherwise 
viable embryo and consequent spontaneous abortion (Burgoyne et al., 1983).  
Is mosaicism necessary for survival in Turner syndrome? 
The high percentage of fetal and embryonic miscarriage for karyotype 45,X points to the 
necessity of mosaicism for survival (Held et al., 1992, 1993). Natural selection does not 
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prevail when mosaicism is operative (Hook et al., 1983; Hassold et al., 1988), though the 
resulting phenotype is similar. Current hypothesis argues for the existence of a feto-
protective effect (Porter et al., 1969; Held et al., 1992) of one or more genes on the X or 
Y chromosome.  
Newborn period: 
The newborn may present with edema of the hands and feet, thick nuchal folds, 
cardiovascular malformations, like coarctation of aorta or hypoplastic heart, bicuspid 
aortic valve, aortic aneurysms etc., Genito-urinary abnormalities include horse-shoe 
kidney, silent hydronephrosis, malrotation etc., and auto-immune disorders like 
hypothyroidism, diabetes mellitus, inflammatory bowel diseases, rheumatoid arthritis 
may also be seen. A variety of somatic abnormalities like short neck with webbed 
appearance, low hairline at the back of the neck, micrognathia and low set ears are typical 
features of Turner syndrome. Weight and height at birth are below the mean for normal 
infants. Turner syndrome may be suspected in the newborn period because of a 
congenital heart defect that can be life threatening. Puffiness of hands and feet at birth are 
attributed to lymphatic obstruction and multiple pigmented nevi may be seen.  
Childhood period:  
The usual presenting feature in childhood is unexplained short stature, an invariant sign. 
Skeletal maturation is normal or only slightly delayed during childhood, but lags in 
adolescence due to sex steroid deficiency. They may also present with some of the 
skeletal features such as short fingers and toes, irregular rotations of the wrist and elbow 
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joints. Linear growth is attenuated in utero and statural growth lags during childhood and 
adolescence. Developmental problems such as speech delay and neuromotor deficits as 
well as learning disabilities of variable severity are common, though mental retardation 
(IQ<70) is rare. Cardiac anomalies that were previously not detected may also become 
apparent during childhood. 
Adolescent period: 
 In adolescence failure to initiate puberty along with primary or secondary amenorrhea 
and absence of breast development is the common feature in Turner individuals. The 
short stature may also be marked in adolescence. 
Adult period: 
As in adolescents, the presenting features of adult women with Turner syndrome are also 
related to hormonal failure, which include amenorrhea, infertility and premature 
menopause with raised levels of luteinizing and follicle stimulating hormones. 
In rare cases, enough ovarian development persists that the Turner syndrome patient 
undergoes normal pubertal maturation (with modest growth spurt) and menarche, and 
then goes into premature menopause. This was first reported in a 141/2 year old Turner 
girl who entered puberty at 10 years of age, experienced menarchy at 11 years, and had 
regular menses thereafter (Weiss et al., 1971).  
In spite of the previous concept that “the gonad does not develop in Turner syndrome” 
(Jaffe, 1986), Carr and associates recognized that the ovaries are normal in early fetal life. 
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Nevertheless at birth most of them have recognizable ovaries (Carr et al., 1968). In vast 
majority of cases the high rate of follicular atresia into dysgenetic streak gonads typical 
of Turner syndrome occurs in the early first decade of life. However, in some cases 
follicular loss is more gradual, and varying numbers of follicles persist longer. 
The number of follicles is sometimes sufficiently adequate that antral follicles are capable 
of secreting estrogen that results in initiation of feminization in perhaps 5 to 10% of 
Turner syndrome. If a major number of antral follicles are at a menopausal level at this 
time, puberty does not progress to menarche. 
Philip and Sele reported a similar ovarian picture in a fertile patient with 45,X Turner 
syndrome (Philip et al., 1976). The duration of menstrual periods in between is variable 
and ranges from nil to decades. If menstruation persists long enough, fertility is possible 
(Abir et al., 2001) However, fertile patients apparently have a relatively high incidence of 
fetal wastage and chromosomal non-disjunctional abnormalities, including Turner and 
Down syndrome (King et al., 1978). Spontaneous pregnancies have also been recorded. 









Table 2: Summary and percentage of occurrence of some of the physical findings in 
Turner syndrome 
(Goldman et al., 1982; Hall et al., 1990; Gotzsche et al., 1994; Hulcrantz et al., 1994; 
Haddad et al., 1999).  
Finding                                                                                Incidence (%) 
Short stature                                                                                 98-100 
Gonadal dysgenesis               95-98 
Short neck                                                                                     80 
Broad chest                                                                                   75 
Hearing impairment                                                                      50-70 
Cubitus valgus                                                                              45-75 
Renal abnormalities                                                                      37-60 
Nevi                                                                                              25-70 
Cardiovascular malformations                                                     20-55 
Lymphoedema                                                                              21-70 
Diabetes mellitus                                                                          40              
Low posterior hairline                                                                  40          
Short metacarpals                                                                         35-65 
Thyroiditis                                                                                    35 
Genu valgum                                                                                30 
Webbed neck                                                                                23  
Extracted from: Turner syndrome in a life span perspective by Albertsson-Wikland and 
Ranke, research and clinical aspects : proceedings of the 4th International Symposium on 
Turner Syndrome, Gothenburg, Sweden, 18-21 May, 1995 / editors, Kerstin Albertsson-
Wikland, Michael B. Ranke. Amsterdam ; New York : Elsevier, 1995. 
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2.5: Fluorescence in-situ hybridization: 
Fluorescence in-situ hybridization (FISH) is a technology utilizing fluorescently labeled 
DNA probes (with a fluorescent dye or a hapten, usually in the form of fluor-dUTP or 
hapten-dUTP) to detect or confirm gene or chromosome abnormalities that are generally 
beyond the resolution of routine cytogenetics. The sample DNA (metaphase 
chromosomes or interphase nuclei) is first denatured a process that separates the 
complimentary strands within the DNA double helix structure. The fluorescently labeled 
probe of interest (also single stranded) is then added to the denatured sample mixture and 
hybridizes with the sample DNA at the complimentary sites as it reanneals (or reforms 
itself) back into a double helix. This attachment can be seen as a fluorescent probe signal 
by a fluorescence microscope and the sample DNA can be scored for the presence or 
absence of the signal.  
Figure 5: Illustration of FISH 
  
From NHGRI website.   http://www.genome.gov/page.cfm.pageID=10000552 
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2.5.1: Probes in FISH:  
There are different types of FISH probes used for various purposes. 
Gene-specific probes or locus specific probes:  
These probes target specific genes or specific nucleic acid sequences within the 
chromosomes approximately ranging from 110-200 kbs. These sequences of genes of 
interest are inserted into plasmids, cosmids, BACs and YACs. These probes have proven 
particularly useful in the study of microdeletion syndromes, where the absence of a gene 
often goes undetected by conventional banding methods. Gene-specific probes are also 
useful for mapping genes on chromosomes.  
Centromeric probes: 
These probes bind to repetitive sequences that are specific to the centromeric regions and 
are used specially for enumeration. Centromeres frequently contain A–T-rich tandem 
repeats, several hundred to thousand times in the centromeric regions each about 106 to 
108 bp in size. They belong mainly to the alpha satellite (50-52) or satellite III families. 
Alpha satellite sequences comprise of 171 bp monomers, whereas satellite III is made of 
5 bp monomers. The beta satellite probes (Oncor) hybridize to the heterochromatic 
regions on chromosome 1 and the acrocentric chromosomes 13, 14, 15, 21 and 22 (Gole 
et al., 1997). Centromeric probes have applications in the identification of marker 
chromosomes and numerical chromosome abnormalities in interphase nuclei and sex 
determination in prenatal diagnosis. 
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Telomeric probes: 
They recognize the repetitive sequence TTAGGG, and can be used to visualize all 
telomeres simultaneously. Telomeric probes and subtelomere-specific probes are used to 
identify cryptic chromosomal translocations such as those occurring in cases of unknown 
mental retardation and for telomere length measurement.   
Whole chromosome probes or Chromosome-painting probes: 
DNA pools from each human chromosome are directly labeled with one or more of 5 
fluorophores in a combinatorial fashion resulting in a unique color signature of each of 
the 24 chromosomes. This technique is useful for identifying chromosome arms that are 
involved in translocations, as well as for marker chromosomes and ring chromosomes 
(Carter et al., 1992).   
2.5.2: Commonly used fluorescent dyes: 
The most frequently used fluorochromes for the detection of the FISH signals are FITC 
(fluorescein isothiocyanate) that emits a green fluorescence and dyes with orange or red 
fluorescence, such as Cy3, or TexasRed. Another commonly used fluorochrome in FISH 
experiments is Cy5 that emits in the far red/close infrared. As this fluorescence is not 
visible to the naked eye it would need detection by an infrared sensitive camera mounted 
on the microscope. 
Since the emission spectra of some of the dyes partly overlap the selection of 
fluorochromes in multi-color experiments is often a compromise. To achieve a good 
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separation of dyes filters which do not fit 100% the emission maximum of the particular 
dye have to be used. Thus, only part of the actual emission spectrum of the fluorochrome 
is utilized to avoid "cross talk" with the emission of another fluorochrome (Table 3).  
Table 3: Excitation and emission maxima of various fluorochromes used in FISH 
experiments  
Extracted from Chambrios molecular cytogenetics 
http://www.chrombios.com/WebFinals/AboutFISH 
Counter staining chromosomes and nuclei 
For FISH experiments, chromosomes and cell nuclei are generally counter-stained using 
a fluorescent dye that is specific for DNA. The most common dye is DAPI (4´, 6-
Diamidino-2-phenyl-indol) that stains the chromosomes and cell nuclei resulting in a 
bright blue fluorescence. Another common counter stain is propidium iodide which 
shows a red fluorescence. 
 
 
  Blue Turquoise Green Orange Red 
Dyes DAPI DEAC FITC/R110 TAMRA/Cy3 TexRed/Cy3.5 
ExMax. 358 426 494/500 552/550 590/581 
EmMax. 461 480 517/525 575/570 612/596 
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2.5.3: Applications of FISH: 
FISH can be used in interphase as well as metaphase for analysis of chromosomal 
anomalies. In the interphase it is mainly used for aneuploidy detection. In the metaphase 
it can be used for detection of not only aneuploidies, but also structural rearrangements 
e.g. deletions, duplications, translocations etc. Based on this, it is utilized in diagnosis as 
well as prognosis in fields of   
• Prenatal diagnosis   
• Cancer cytogenetics 
•  Genetic diagnosis of preimplantation embryos  
• Adolescent menstrual disorders, infertility in adults, pediatric disorders 
2.5.4: Advantages of FISH: 
Fluorescence in situ hybridization (FISH) is a rapid reliable technique in molecular 
cytogenetics. It supplements conventional karyotyping and in some cases provides 
additional information. The primary advantage of interphase FISH is that it can be 
performed very rapidly, if necessary within 24 hours, as cell growth is not required. 
Hence, it permits analysis of cells in interphases as well as metaphase. FISH is a sensitive 
and useful adjunct to cytogenetic testing for the detection of abnormalities of 
chromosomal structure or numbers e.g. deletions, translocations, duplications, and 
aneuploidy. It is often the method of choice for detection of microdeletions. A large 
number of cells are available for quantitative analysis by FISH and it helps in detection of 
minimal residual disease and disease recurrence, as a very small percentage of abnormal 
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cells can also be identified. The distinct hybridization signals seen in metaphase as well 
as interphase nuclei help in rapid diagnosis, thereby shortening the reporting time. It also 
aids the confirmation of chromosomal anomalies in standard karyotyping for prenatal and 
pre-implantation genetic diagnosis and cancer cytogenetics. 
2.5.5: Fluorescence in-situ hybridization (FISH) as a sensitive tool in detecting 
mosaicism: 
FISH can diagnose chromosomal mosaicism as early as the preimplantation stage by 
studying polar bodies or later in blastomeres. This is followed by analysis at early 
gestational ages by testing chorionic villi cells and later by amniotic fluid or fetal blood 
analysis. Peripheral blood lymphocytes or skin fibroblasts are utilized for analysis in the 
postnatal period. Held et al., (1992) demonstrated the power of FISH to detect low-level 
mosaicism in peripheral blood cells. In their studies using conventional cytogenetic 
methods alone, the prevalence rate of 45,X in 45,X mosaics was 54.3%, a figure in good 
agreement with the 55-61.2% range reported in four major studies (Palmer et al., 1976; 
Hall et al., 1982; Ranke et al., 1983; Park et al., 1993). However, on re-investigation by 
both conventional cytogenetic methods and FISH the prevalence rate dropped to 30% 
leading to a decrease in the ratio 45,X mosaics from 1.6 to 0.5. According to them, the 
sensitivity of detecting micro mosaics can be further improved by using FISH and PCR 




2.6: Hypothesis of this study: 
In many instances there are features of the Turner syndrome, but the resulting karyotype 
is normal by conventional method. When karyotype analysis does not correlate with the 
clinical phenotype, it is very puzzling for the clinicians as well as distressful to the 
patients. One of the reasons for this discrepancy could be that some of the cases may have 
a low-grade mosaicism i.e. a small minority of cells may be monosomic for the X 
chromosome.  
Vice versa, the high percentage of fetal and embryonic miscarriage for karyotype 45,X 
points to the possibility of presence of a cell line with 46,XX for survival either in the 
fetus or extra-embryonic tissues of live born 45,X Turner syndrome females (Held et 
al.,1992, 1993).  
2.7: GOALS OF THE STUDY: 
1) Detection of the percentage of monosomic X cells in karyotypically normal patients 
with Turner stigmata by FISH technique (Group I).  
2) Detection of the percentage of normal 46,XX cells in karyotypically proven Turner 
patients (Group II).  
3) Proposition of a cut-off value for abnormal X cell incidence beyond which low grade 
mosaicism can be classified as significant. This was achieved by analyzing a control 
group of women, age matched to the patients (Group III).  
 








PATIENTS & METHODS 






Study groups included patients with Turner stigmata who were referred by clinicians for 
G-banded chromosomal karyotype analysis to confirm the diagnosis of Turner syndrome. 
After analysis, those patients who showed a normal karyotype were grouped as study 
group I and FISH was done to exclude low-grade X chromosome mosaicism. Patients 
with 45,X cells on G-banding and confirmed as having Turner syndrome were grouped as 
study group II and the percentage of normal 46,XX cells was investigated. 
Study group I: Patients with Turner stigmata but normal karyotype (n=11). 
Study group II: Turner patients with a 45,X cell line (n=17). 
Control group III: This group included the control group of normal fertile females (n=25). 
An information leaflet about the procedures and implications was explained to the 
patients. Informed consent was obtained from all the participants in this study.  
A form (Appendix 2) with details of the clinical features was given to the consultants and 
the clinical features for referral are presented below. 
3.1.1: Group I: - Details of karyotypically normal patients with Turner stigmata : 
Case 1: 
A 15-years-old Chinese girl presented with short stature, webbed neck, widely spaced 
nipples, shield type of chest and primary amenorrhea. Other features included slant eyes, 
mild proptosis with frontal bossing, low-set ears, high arched palate, increased carrying 
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angle of the elbow, finger and toenail deformities, multiple nevi, low posterior hairline, 
clinodactyly and mild prolapse of atrial and mitral valves in the heart. Her bone age was 
less than her chronological age. Her thyroid hormone profile was normal [T4:15.5 pmol/l 
(11-22), TSH: 1.09 mU/l (0.5-4)]. 
Case 2: 
A 15-years-old Chinese girl presented with short stature (139.5cms), low-set ears and 
high arched palate. There was no history of primary or secondary amenorrhea. 
Case 3: 
A 31-years-old Chinese lady presented with secondary amenorrhea of 14 years duration. 
Other features included short stature, thick nuchal fold and wide carrying angle of the 
elbow.  
Case 4: 
A 17-years-old Indian girl presented with primary amenorrhea, short stature, 
microcephaly and low IQ. 
Case 5: 
A 13-years-old Malay female presented with short stature, hirsutism and elevated 




A 21-years-old Chinese female presented with Primary amenorrhea. She was of average 
height.  
Case 7: 
A 15-years-old Chinese girl presented with short stature, prepubertal ovarian failure 
(FSH: 3.9IU/l, LH :< 0.1IU/l) and primary amenorrhea.  
Case 8: 
A 16-years-old Chinese girl presented with short stature, short neck, cubitus valgus, high 
arched palate and amenorrhea.  
Case 9: 
A 33-years-old Indonesian female presented with secondary amenorrhea and was 
diagnosed as premature ovarian failure. 
Case 10: 
A 19-years-old Chinese girl presented with features of Turner syndrome which included 
amenorrhea, short stature, webbed neck, cubitus valgus, high arched palate and delayed 
bone age. Her breast development was at stage 1. She was also diagnosed with 




A 17-years-old Indian girl presented with secondary amenorrhea. She attained menarche 
at 16 years of age. Subsequently, she was diagnosed with premature ovarian failure and 
follicle stimulating hormone level was high. 
3.1.2: Group II: -Details of karyotypically proven Turner patients:  
Case 1: 
A 16-years-old girl presented with short stature, high arched palate, multiple pigmented 
nevi and finger and toenail deformities (hyperconvex nails). 
Case 2: 
A 20-years-old Chinese lady diagnosed as Turner syndrome presented with amenorrhea, 
short stature, webbed neck, high arched palate etc. She was on hormone replacement 
therapy. 
Case 3: 
A 9-years-old Chinese girl presented with short stature, high arched palate, low-set ears, 
multiple pigmented nevi, finger nail and toenail deformities (hyperconvex nails). 
Case 4: 




A short 13-years-old Chinese girl presented with delayed puberty (delayed breast 
development), short stature and multiple pigmented nevi. 
Case 6: 
A 32-years-old Chinese female presented with secondary amenorrhea diagnosed as 
premature menopause (increased FSH: 100IU/L; decreased estradiol: 19 pmol/L). 
Case 7: 
A 17-years-old Chinese female presented with features of Turner syndrome such as 
amenorrhea and short stature. 
Case 8:  
A 6-years-old Malay girl presented with short stature, low-set ears, and low posterior 
hairline. Her karyotype showed 45,X. 
Case 9: 
A 9-years-old Malay girl presented with short stature, low posterior hair line and low-set 
ears. 
Case 10: 
A 25-years-old Chinese female presented with short stature and primary amenorrhea. 
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Case 11: 
A 21-years-old Chinese lady presented with primary amenorrhea and low-set ears. She 
was of average height. She had no other physical abnormalities. She was on hormonal 
therapy. 
Case 12: 
A 34-years-old Chinese female presented with secondary amenorrhea. She attained 
menarche at the age of 12 years after which her periods were irregular and stopped 
subsequently. She was short and had low-set ears, high arched palate and low posterior 
hairline. She was on hormonal therapy. 
Case 13: 
A 20-years-old Chinese female presented with primary amenorrhea and short stature. She 
had no other stigmata. She was on hormonal therapy. 
Case 14: 
A 16-years-old Chinese lady, a known case of Turner syndrome on hormonal therapy, 
presented with short stature and amenorrhea. 
Case 15:  




A 30-years-old lady presented with amenorrhea and short stature and she was on 
hormonal treatment. 
Case 17: 
A 16-years-old female presenting with features of Turner syndrome like primary 
amenorrhea and short stature. 
3.1.3: Group III:-Details of the control females: 
Control 1: 
A 25-years-old Indian female presented with normal menstrual history and hormone 
profile. She was of average height with no abnormal physical findings. 
Control 2: 
A 26-years-old normal Indian female with regular menstrual history. Physical 
examination and hormonal profile were normal. 
Control 3: 
A 29-years-old healthy Indian female with normal menstrual history. She was of average 





A 27-years-old Indian pregnant female with an uneventful previous pregnancy which 
ended in a full term normal delivery. Her hormonal profile was normal before pregnancy. 
She was 155cms tall. 
Control 5: 
A 26-years-old tall (160cms), healthy Chinese had regular menstrual history. Her 
hormonal profile was normal.  
Control 6:  
A 23-years-old healthy Burmese female had normal menstrual history and hormone 
profile. She was 152 cms tall. 
Control 7: 
A 29-years-old healthy, tall (169cms) Indian female with a previous full term normal 
delivery. She attained menarche at 13years of age with regular menstrual history (4/24). 
Physical examination was normal. 
Control 8: 
A 35-years-old normal, healthy Chinese female with regular menstrual history had 




A 33-years-old healthy, tall (162cms) Indonesian pregnant female had a previous full 
term normal delivery. She attained menarche at about 12years of age and had regular 
menses. Physical examination was normal. 
Control 10: 
A 31-years-old healthy Indian primigravida with normal menstrual history. She was of 
average height (157.5cms).  
Control 11: 
A 35-years-old normal Malaysian pregnant female with two previous uneventful full term 
normal deliveries. She attained menarche at 10 years of age and had regular menstrual 
history.  
Control 12: 
A 26-years-old pregnant Indian female with a previous full term normal delivery, had a 
normal menstrual history. She attained menarche at about 13 years of age.  
Control 13: 
A 38-years-old tall (168cms), healthy Indian female with two previous full term 




A 31-years-old tall (165cms), healthy pregnant Indian female had regular menstrual 
history. Her previous pregnancy ended in a full term normal delivery. She attained 
menarche at the age of 12 years. Physical examination was normal. 
Control 15: 
A 30-years-old pregnant Indian female had normal menstrual history. Her previous 
pregnancy was uneventful and ended in a full term normal delivery. She was 160 cms 
tall. Her physical examination was normal.  
Control 16: 
A 34-years-old healthy Indian lady had two previous uneventful pregnancies and full 
term normal deliveries. Her menstrual history was normal and she was of average height 
(158cms). Physical examination and hormonal profile was normal. 
Control 17: 
A 32-years-old healthy pregnant Indian lady had a previous full term normal delivery. 
She attained menarche at the age of 12 years and had regular periods. Physical 
examination was normal. She was of average height (155cms). 
Control 18: 
A 28-years-old healthy pregnant Chinese female had a previous uneventful pregnancy  
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  and a full term normal delivery. She attained menarche at the age of 11 years and had a 
regular menstrual history. Her physical examination was normal. She was 160cms tall. 
Control 19: 
A 27-years-old healthy primigravida of Indian origin had a regular menstrual history. She 
was 165 cms tall. She attained menarche at the age of 10 years. Her physical examination 
was normal.  
Control 20: 
A 32-years-old healthy pregnant Chinese lady had a previous full term normal delivery. 
She attained menarche at the age of 12 years and had a regular menstrual history. She was 
160 cms tall and her physical examination was normal. 
Control 21:    
A 27-years-old healthy primigravida of Indian origin had a regular menstrual history. She 
was 167 cms tall and had a normal physical examination. 
Control 22:  
A 26-years-old Indian primigravida had a regular menstrual history. She attained 





A 32-years-old healthy pregnant Indian female had a previous uneventful pregnancy and 
a full term normal vaginal delivery. She attained menarche at 12 years of age and had a 
regular menstrual history. She was 160 cms tall and had a normal physical examination. 
Control 24:  
A 30-years-old pregnant Indian female had a normal, regular menstrual history. Her 
previous pregnancy was uneventful and she had a full term normal vaginal delivery. She 
was 155 cms tall. Her physical examination was normal. 
Control 25: 
A 28-years-old healthy Indian primigravida had a regular menstrual history. She attained 










In all the groups, mitogen stimulated short-term peripheral blood lymphocyte cultures 
were carried out and metaphase spreads were treated with trypsin-Leishman to obtain G-
bands using the standard techniques. 5 metaphases were analyzed and 100 G-banded 
metaphase spreads were scored with special reference to the X chromosomes. 
FISH analysis using  X centromeric probes (DXZ1) labeled in spectrum green and LSI 
STS Xp region probes labeled in spectrum orange (as an internal control) from Vysis was 
performed. DAPI was used as a counterstain and slides were visualized under a 
fluorescence microscope using the appropriate filters. 5000 cells (both metaphases and 
interphases) were scored.  
3.2.1: Specimen collection  
Peripheral blood was collected from two study groups and one control group of human 
volunteer donors in lithium heparin Vacutainer tubes. All collection and research 
protocols were approved by the local ethical review boards. The blood samples were kept 
at room temperature and processed within 3-4 hrs on the same day. 
Lymphocyte culture 
 Mitogen (phytohaemagglutinin) stimulated short-term peripheral blood lymphocyte 




• To 5mls of complete media about 0.4mls (approximately 9 drops) of heparinised 
blood was added and incubated at 37˚C for 70-71 hrs.  
Mitotic arrest:     
The lymphocytes were arrested at metaphase stage because the chromosomes are 
maximally condensed and can be visualized well under the microscope. Colcemid, an 
analog of colchicine that is less toxic to cells is used for this process.  Three parameters: 
mitotic index, spreading and chromosome condensation are affected depending on 
Colcemid concentration and time of exposure. Colcemid continues to be active until the 
addition of fixative.  Higher concentrations and longer exposure times result in good 
mitotic index but shorter chromosomes.  
•   100µl of Colcemid (Sigma Cat no.9754) 0.6µg/ml was added to T25flask after 70-
71hrs and incubated for about 60 minutes at 37˚C.  
• After the Colcemid incubation, the blood cultures were centrifuged at 1200 rpm for 5 
minutes in a Beckman centrifuge. 
Hypotonic treatment: 
The addition of the hypotonic solution, potassium chloride (KCl), will result in water 
rushing into the cells due to the concentration gradient caused by the less-than-
physiological concentration outside of the cells. This results in swelling of cells and 
further separation of the chromosomes. 
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• Prewarmed 0.075 M KCl (0.56%) was added to the cells and incubated at 37˚C for 
about 15 minutes. Cell suspension was centrifuged at 1200rpm for 5 minutes. 
Fixative treatment: 
With the addition of Carnoy’s fixative (3:1:: absolute methanol: glacial acetic acid), each 
cell is preserved in its swollen shape by extracting the surrounding material, removing 
lipids and denaturing proteins thus making the cell membrane very fragile, which helps 
chromosome spreading and fixing the chromosomes. Chemical changes make the cell 
hard (not as fragile as in hypotonic), but remaining a swollen sac of suspended 
chromosomes.   
• Supernatant was discarded (buffy coat seen at this stage) and 7.5mls of cold freshly 
prepared fixative was added slowly while vortexing. The cell suspension was chilled 
at 4˚C for about 30-45 minutes or overnight. The cells were centrifuged at 1200rpm 
for 5 minutes in the Beckman centrifuge. 
• Supernatant was discarded (contains lysed red blood cells and cellular debris) and the 
cells were resuspended in about 5mls of Carnoy’s fixative and washed  2-3 times till 
the supernatant was clear (until all red cells were lysed and a white cell pellet was 
observed). The pellet was stored at 4˚C until chromosome preparation. 
•  Metaphases were prepared on moist slides (by dropping cell suspension) and then 
checking under phase contrast microscope for the quality of metaphase spread. 
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Slides were aged by 
• Baking in the oven at 90˚C for 1 hour. 
• Treating with ultra violet exposure for 55-60 seconds. 
• Treating with methanol for 5 minutes. 
• Treating with prewarmed 25% H2O2 for 1.5-2 minutes  
3.2.2: GTL (G-bands by trypsin using Leishman) banding: 
Giemsa bands are obtained by digesting the chromosomes with proteolytic enzyme 
trypsin. With G-banding chromosomes exhibit light and dark stained regions along their 
length. The mechanism is not clear but it is hypothesized that the differences between 
positive and negative bands may be due to the distribution of chromosomal proteins and 
DNA (dark bands are relatively rich in disulfides and the light bands are rich in 
sulfhydryls). Further the dark bands are gene poor and the light bands are gene rich 
regions. 
• Slides were treated with Trypsin (1:40:: Trypsin: 0.9% NaCl) for 20-30 seconds. The 
slides were then stained with Leishman’s dye (1:5:: Leishman stain: PBS) for 3.5-4 
minutes and washed with phosphate buffered saline (PBS). 
• In this study 5 metaphases were analyzed in detail, counted 25 entire metaphases and 




3.2.3: Dual color fluorescence in-situ hybridization:  
The Vysis LSI Steroid Sulfatase (STS) probe, a dual color probe containing the Spectrum 
Orange STS (Xp22.3) probe and the Spectrum Green CEP X control probe (Xp11.1-
q11.1) was used (Vysis-32-191004) (Fig.6). Two independent observers did FISH 
analysis. The supervisor or senior staff of the cytogenetic lab, Department of Obstetrics 
and Gynecology, always analyzed 500 cells out of 5000. The probe used from Vysis was 
100% efficient (100% sensitive and 100% specific) as stated by the Quality Assurance 
certificates on each batch of probe used (Appendix 3).  
After the UV treatment of the slides for 40 seconds, probe along with the hybridization 
buffer was applied on the slide and covered with a coverslip and sealed with rubber 
cement.  
• The chromosomes were co-denatured along with the probe at 75˚C for 1 minute in 
the Vysis Hybrite machine. 
• Hybridization was carried out for 16-24 hours at 37˚C. 
• After the hybridization was complete, the slides were washed using the rapid wash 
procedure to wash off non-specific bound probe. 
Rapid Wash procedure:  
Wash solution 1: 0.4X SSC/0.3% NP-40  
Wash solution 2: 2XSSC/0.1% NP-40  
• Slides were kept in the first wash solution at 73±1˚C for 2 minutes in a water bath. 
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•  Slides were gently rinsed in the second wash solution for 5minutes at room 
temperature.  
Counterstaining and visualizing the hybridization: 
•  The chromosomes were counterstained using DAPI (4',6’-Diamidino-2-  
phenylindole) from Vectashield. 
•  The slides were visualized under a fluorescence microscope with the appropriate 
filters. 
 The Applied Imaging FISH software was used for image analysis. About 5000 cells 
(both metaphases and interphases) were scored for the X chromosome. Signals were 
classified as individual signals when the distance between them was greater than the 
diameter of a single signal. As the X centromeric probe was larger (thousands of 




















































                                                                         4. RESULTS   
4.1: Group I- Results of patients with Turner stigmata with a normal karyotype: 
In this group FISH analysis showed a low percentage of monosomy X cells not detected by the routine karyotyping. 
Table 4: Summary of FISH results in patients with Turner stigmata with a normal karyotype 
Case 
No. Age/sex     Race Phenotype Karyotype FISH-Cultured
1   15/F Chinese  PA,SS,WN,CV,LSE,LPH  46,XX[100] 
Total:     5469 cells  
XX   :     5458   (99.8%) 
X      :         11    (  0.2%) 






Total:     6291 cells  
XX   :    6285  (99.85%) 
X      :          6  (   0.15%) 
 
3    31/F Chinese SA,SS,WN, 46,XX[100]
Total:    3301 cells 
XX   :   3220  (97.39%) 
 X     :       81  (  2.51%)  
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 4    Indian PA,M,TNF 46,XX[100]
 
Total:     5000 cells 




























 6,XX[100]X:               49     (0.97%) 
XXX:         16     ( 0.33%)         
 
Total:      5000 cells 
XX:         4922   (98.45%) 
 X:               54   (  1.07%) 
XXX:          24    (  0.48%) 
] 
Total:       5613 cells 
XX:          5460  (97.28%)  
X:              53     (  0.94%) 
XXX:       100    (  1.78%) 
 
Total:    4586 cells  
 XX:      4509      (98.33%) 
X :             76      (  1.65%) 
XXX:           1      (  0.02%) 
 
Total:     5441 cells  
XX:         5412    (99.47%) 
X :               25    (   0.46%) 
XXX :           4     (  0.07%) 
Total:      5328 cells 
XX:         5270      (98.91%) 
X :               46      (  0.86%)  









10    33/F Chinese POF 46,XX[100]
Total:      4942 cells  
XX:        4806      (97.36%)   
X:               86      ( 1.74%)   
XXX :        50       ( 1     %)    
 
11     20/F Indian SA 46,XX[]100]
Total:       5000 cells 
XX :         5000      (100%) 
X:                   0      (    0%) 
 
2.74%
CV(Cubitus Valgus); HAP(High arched palate); LPH(Low posterior hairline); LSE (Low Set Ears); M(Microcephaly);MA(Mullerian 
agenesis);MPN(Multiple pigmented nevi);  PA(PrimaryAmenorrhoea); POF(Premature ovarian failure); SA(Secondary Amenorrhea); 







4.2: Group II: Results of Turner patients with a 45,X cell line by G-banding: 
Table 5: Summary of FISH results of Turner patients with a 45,X cell line by G-banding 
Case 
number      Age/Sex Race Phenotype Karyotype FISH
1     16/F Chinese SS,HAP,MPN 45,X[47]/46,XX[53]
Total:   6923 cells  
XX:      4494  (64.9%) 
X :        2429  (35.1%) 
 
2    20/F Chinese PA,SS 45,X[94]/47,XXX[6]
Total:    3181cells,  
XX:           16  ( 0.5%) 
X:          3000  (94.3%) 
XXX:       165  ( 5.2%) 
3    9/F Chinese SS,HAP,MPN,LSE  45,X[94]/46,X,+r[6]
Total:     2209 cells 
XX:            92  ( 4.2%) 
X:           2117  (95.8%) 
4     16/F Malay SN,SS,HAP 45,X[9]/ 46,X,der(X) [51] 
Total:      2008 cells  
XX:        1596  (79.5%) 
X :            412  (20.5%) 
99.5%
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 5    13/F Chinese DP,SS, 45,X[241]/46,XX[9]
Total:      4516 cells  
XX:             61  ( 1.35%) 
X:            4425  (97.99%)  
XXX:          30  ( 0.66%) 
6    32/F Chinese SA,POF 45,X[72]/47,XXX[28]
 
Total:     5316 cells 
XX:          167   (  3.14%) 
X:           3437   (64.66%) 
XXX:     1712   (32.2%) 
98.65%
7     17/F Malay PA 45,X[98]/46,X,del(X)[2]
Total:      5798 cells 
XX:            11   ( 0.21%) 
X :           5749  (99.13%)  
Xp-:            38   ( 0.66%) 
8     6/F Malay SS,LSE,LPH,CV 45,X[100]
Total:      4995 cells 
XX :             3   ( 0.06%) 
X:            4990 (99.9%) 
Xp-:              2   (0.04%) 
9    9/F Malay
SS,LPH,LSE 
 45,X[10]/46,XX[90]
Total:      3001 cells 
XX:         2665   (88.8%) 
X:              336   (11.2%) 
10    16/F Chinese PA,SS 45,X [100]
Total:      5005 cells 
XX :             5     (  0.1%) 





11    21/F Chinese PA,LSE 45,X[30]/46,XX[70]
Total :      5000 cells 
XX :        3223   (64.46%) 














LPH  45,X[85] / 46,XX[15] 
 
 
Total:       4349 cells 
XX:            378 ( 8.69%) 
X:            3500  (80.48%) 
XXX:         471 (10.83%) 





Total:       5000 cells 
XX:          4750  (95 % ) 
X :               250 ( 5%   ) 
14    16/F Chinese SS,PA 45,X[99]/46,XX[1]
 
Total:        5000 cells 
XX:              97 (1.95%) 
X :            4903  (98.05%) 
15    21/F Chinese PA 45,X[55]/46,XX[45]
 
Total:      6270 cells 
XX :        2660 (42.42%) 
X :           3600 (57.42%) 
XXX:           10 (  0.16%) 




Total:       5001 cells 
XX:          2400 (47.99%) 
X :            2600 (51.99%) 


















Total:       5000 cells 
XX:          2000   (40%) 
X:             3000   (60%) 
CV(Cubitus Valgus); HAP(High arched palate); LPH(Low posterior hairline); LSE (Low Set Ears); 
M(Microcephaly);MA(Mullerian agenesis);MPN(Multiple pigmented nevi);  PA(PrimaryAmenorrhoea); POF(Premature ovarian 
failure); SA(Secondary Amenorrhea); SN(Short neck); SS(Short stature); TNF(Thick nuchal fold); WN(Webbed Neck)  
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4.3: Group III -Results of the control group: 
Table 6: Summary of FISH results of controls 
25 normal fertile females age-matched to the patients were also studied as the controls.  
Case      Age/Sex Race Phenotype Karyotype FISH
1 25/F  Indian  Normal 46,XX[100] 
Total:        5297 cells 
XX:           5268  (99.45%) 
X:                  20   ( 0.38%) 
XXX:              9    (  0.17%) 
2  26/F  Indian  Normal 46,XX[100] 
Total:        5134 cells 
XX:           5116  (99.65%) 
X:                  12  ( 0.23%) 
XXX :             6  ( 0.12%) 
3 29/F  Indian  Normal 46,XX[100] 
Total:          5084 cells 
XX:             5065  (99.63%) 
X :                   19  (  0.37%) 
4   27/F Indian
Normal,  
G2,P1,L1 
 Ht:155cms 46,XX([100] 
Total:          5025 cells 
XX:             5010  (99.7%) 
X:                    13  ( 0.26%)  
XXX:                2   (  0.04%) 
5   26/F Chinese
Normal,Primigravida,Ht-
160cms 46,XX([100] XX:               5035 (100%) 
Total:            5035  cells 
6    23/F Myanmar Normal,Ht:152cms,unmarried 46,XX[100]
Total:       5047 cells 
XX:          5024  (99.54%) 
X:                 22   ( 0.44%) 





7     29/F Indian Normal,Ht-169cms,P1L1 46,XX[100]
Total:         5020 cells 
XX:           5018    (99.96%) 
X:                    2    ( 0.04%) 
8     36/F Chinese Normal,Ht-55cms 46,XX[100]
Total:          4950 cells  
XX:             4932   (99.64%) 
X:                    13   ( 0.26%) 
XXX:                5   (  0.10%) 
9     33/F Chinese Normal,G2P1L1,Ht-162cms 46,XX[100]
 
Total:            5191 cells 
XX:               5173  (99.65%) 
X:                      12   ( 0.23%)  
XXX:                   6  ( 0.12%) 
10   31/F Indian
Normal, Pregnant  
Ht-157.5cms  46,XX[100] 
 
Total:             4514 cells 
XX:                4510   ( 99.8%) 
X:                         3   (  0.06%) 
XXX:                   1   ( 0.02%) 
11     35/F Malay Normal,G3P2L2,Ht-168cms 46,XX[100]
Total:             5351 cells 
XX:                5348    (99.9%) 
X:                         3    (  0.10%) 
12     28/F Indian Normal,G2P1L1,Ht-160cms 46,XX[100]
 
Total:             4616 cells 
XX:                4603    (99.72%) 
X:                         9    (  0.2%) 
XXX:                   4    (  0.08%) 
13     33/F Indian Normal,P2L2,Ht:168cms 46,XX[100]
 
Total:              6130 cells 
XX:                 6120     (99.84%) 






14     31/F Chinese Normal,G2P1L1Ht:165cms 46,XX[100]
Total:          5669 cells 
XX:             5654   (99.73%) 
X:                14       ( 0.25%)  
XXX:            1       ( 0.02%) 
15     30/F Indian Normal,G2P1L1,Ht:160cms 46,XX[100]
Total:           5191 cells 
XX:              5184  (99.86%) 
X:                 6        (0.12%) 
XXX:          1          (0.02%) 
16     34/F Indian Normal,P2L2,Ht:158cms 46,XX[100]
 
Total:           5561cells 
XX:              5561   (99.8%) 
X:                       9   ( 0.16%)  
XXX:                 2   ( 0.04%) 
17    32/F Chinese Normal,G2P1L1,Ht:155cms 46,XX[100]
 
Total:           5421 cells 
XX:              5399   (99.6%) 
X :                    17   ( 0.3%)  
XXX:                 5   (  0.1%) 
18     28/F Chinese Normal,G2P1L1,Ht:160cms 46,XX[100]
 
Total:             4455 cells 
XX :               4426   (99.3%) 
X:                         2   0.5%) 
XXX:                   8   ( 0.2%) 
19     27/F Indian Normal,G1P0L0,Ht:165cms 46,XX[100]
 
Total :             5000 cells 
XX:                 5000    (100%) 







20     32/F Chinese Normal,G2P1L1,Ht:160cms 46,XX[100]
Total:               5313 cells 
XX :                5299    (99.7%) 
X:                          9    ( 0.2%)  
XXX :                   5    (   0.1%) 
21   27/F Indian
Normal, Primigravida, 
Ht-167cms 46,XX[100] 
Total:               5221 cells 
XX:                  5216   (99.9%) 
X:                           4   ( 0.08%) 
XXX:                     1    ( 0.02%)         
22      26/F Indian Normal,G1P0,165cms 46,XX[100]
 
Total:                5152 cells 
XX:                   5145   (99.86%) 
X:                            2   ( 0.04%) 
XXX :                     5   (  0.1%) 
23      32/F Indian Normal,G2P1,Ht:160cms 46,XX[100]
Total:                5014 cells 
XX:                  5012    (99.96%) 
X:                           2    (  0.04%) 
 
24      30/F Indian Normal,G2P1,Ht:155cms 46,XX[100]
Total:                5039 cells 
XX :                  5035    (99.92%) 
X :                           3    (  0.06%) 
XXX :                     1    (  0.02%) 
25      28/F Indian Normal,G1P0,Ht:160cms 46,XX[100]
Total:                 5025 cells 
XX:                    5025  (100%) 







Graph 1: Histogram showing the percentage of monosomy X cells and trisomy X cells detected by FISH in control females undetected 
by the standard G- banding  
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Graph 2. Histogram showing the percentage of abnormal cells detected by FISH in study groupI (patients with Turner stigmata with a 
normal karyotype ):  
Percentage abnormal cells detected by FISH in 































Graph 3: Histogram showing percentage of normal and abnormal cells by FISH in the study group II (Turner patients with a 45,X cell 
line):  




















Figure 8: FISH on a metaphase showing two X chromosomes with signals on the X 
centromere and the Xp-arm  
 
 








Figure 10: FISH on a metaphase showing a single X chromosome  
 
Figure 11: FISH on an interphase cell showing a single X with one signal each on X 
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Figure 12: FISH on interphases cells showing three signals each for the X centromere and 
Xp-arm 
 





Figure 14: FISH showing mosaicism in interphase nuclei  










4.4: Statistical analysis: 
Comparison of the statistics of frequency of abnormal X cells between study group I 
(i.e., patients with Turner stigmata but a normal karyotype on G-banding) and the 
control group (group III): 
Eleven patients were studied in this patient study group I and 25 females were studied in 
the control group III. All of them showed a normal 46,XX karyotype with the routine 
cytogenetic techniques. But with FISH, group I showed a percentage of abnormal cells 
which ranged from 0.0%-2.45% (mean: 1.31%, SD 1.03). However, the control females 
showed a lower percentage of abnormal X cells ranging from 0.0%-0.7% (mean: 0.23%; 
SD: 0.185).  
Mann-Whitney U test: 
The main goal was to investigate if there was a significant difference between the 
percentages of abnormal X cells of the control group and the patient group. Mann 
Whitney U test was selected to test this using the software SPSS 12.0. A significant p 
value (p=0.003) was obtained using this test. This test uses the comparison of median 
which is more robust than the mean, especially for this study, as the distribution of the 
samples was skewed. Hence t-test which compares the difference of the means could not 
be used. The incidence of Turner syndrome being very small, a larger sample size could 
not be obtained for t-test. The median of percentage abnormal cells in patient group is 
1.3% (0%~2.74%), while the median of the same in the control group is 0.2% 
(0%~0.7%). 
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4.4.1. Definition of value for low-grade mosaicism:  
The next goal was to determine cut-off value for percentage of abnormal X cells above 
which low-grade mosaicism could be classified as significant. This was because the 
control group also had a low percentage of abnormal X cells, it was necessary to 
determine a value beyond which one can say it is definitely a significant low-grade 
mosaicism. This value was obtained using the Receiver Operating Characteristic curve 
(ROC curve), to obtain a value with maximum sensitivity and specificity.  
Figure 15: ROC curve 













Diagonal segments are produced by ties.
ROC Curve
  
The area under the ROC curve is 0.811(95% CI: 0.621 to 1). 
 70
Table 7: Coordinates of the ROC Curve 
Positive if 
Greater Than 





























The smallest cutoff value is the minimum observed test value minus 1, and the largest 
cutoff value is the maximum observed test value plus 1. All the other cutoff values are the 
averages of two consecutive ordered observed test values. 
From the ROC curve, using a cut-off value of 0.895% (percent abnormal X cells) gives a 
sensitivity of 63.6% and a specificity of 100% while a cut-off value of 0.497% gives 
72.7% sensitivity and 92% specificity.  
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Percentage of normal cells in karyotypically proven Turner patients study group II: 
The next goal was to detect the presence of normal 46,XX cells in typical Turner patients 
with 45,X on G-banding. Out of 17 patients studied, 15 showed normal 46,XX cells with 
routine cytogenetic methods. This percent of normal cells ranged from 0.2% to 95%. But 
two patients among the 17 were pure 45,X with G banding. However, these two patients 
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5: Discussion 
Individuals with Turner Syndrome are phenotypically females with gonadal dysgenesis 
and somatic stigmata, especially short stature but have normal intelligence. Similar 
clinical features were observed in the study group of patients. Of the 28 patients referred 
for chromosomal analysis, 17 were proven to have a 45,X cell line, detected by 
conventional cytogenetic G-banding analysis (Group II). The remaining 11 patients who 
were found to be karyotypically normal (46,XX) formed our study group I. This small 
sample size was a result of stringent criteria for patient selection and exclusion of patients 
with other structural X chromosomal anomalies (e.g. mosaics of 45,X/46,XX with ring X, 
isodicentric X, Xp and Xq deletions). 
 
In group I, 2 out of 11 patients presented with short stature as the primary clinical 
manifestation, 5 out of 11 presented with some form of gonadal dysgenesis and 4 had 
both these features. Similarly in group II, 6 out of 17 presented only with short stature, 5 
out of 17 presented with gonadal dysgenesis and 6 had both the features. Though the 
clinical presentation was identical in both the groups, karyotypes differed.  
 
The patients’ in group I whose clinical presentation suggested a diagnosis of Turner 
syndrome but proved to be karyotypically normal, could be due to the gonadal mosaicism 
reflected in only a small percentage in the peripheral blood, which might be missed by 
conventional karyotyping. Using the formula (Hook, 1977), pn+ (1-p)n=α, (where α is 
0.05 at 95% confidence interval, p is the percent mosaicism excluded and n is the number 
of cells counted), at least 500 metaphases need to be analyzed to prove the presence of 
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low percent abnormal clones (<1%) which is very difficult to do with conventional 
cytogenetic methods. In this study, 5000 cells were scored for abnormal X cells using the 
FISH technique that excludes absolutely all the mosaicism (p=0.000000…). Ten out of 
eleven patients showed a low percentage of 45, X cells ranging from 0.1% to 2.45% with 
FISH technique, but one patient (case 11) did not show mosaicism. There are to date no 
references in literature, which provide us with the significance of this low level abnormal 
X cells in patients with some of the Turner stigmata. There is no information or guideline 
for a baseline value, above which the presence of these abnormal X cells can be 
considered to be the cause for the phenotype. Also, 45,X mosaicism is not uncommon 
and probably a harmless finding in blood cultures from normal women. As a consequence 
of aging, errors occur in cell divisions, leading to the loss of the inactivated X-
chromosome (Surralles et al., 1999). So a low percent of abnormal cells could also be 
present in normal females. 
 
In this study, the control females (group III) showed a percentage of 45,X cells ranging 
from 0.0%-0.7%. Group I had a significantly higher percentage of abnormal X cells as 
compared to that of the controls (p=0.003, Mann-Whitney U test). To obtain a baseline 
value, beyond which low grade X-mosaicism could be classified as significant, the ROC 
curve was derived from the FISH results of group I and group III. Normally statistical 
tests aim for a value with maximum sensitivity and specificity, which in this case is 
0.495% (sensitivity: 72.7%; specificity: 92%). Applying this value, 7 out of 11 patients 
were classified as low-grade mosaics. However, two of the controls (cases 1 and 18 of 
group III), which were absolutely normal were also classified as low-grade mosaics. 
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Since the X chromosome probe used in the FISH experiments had 100% efficiency, a cut-
off value with 100% specificity should be selected to avoid misclassification of the 
controls as low grade mosaics. Hence the cut-off percentage of 0.895% i.e., 1% (rounding 
up to the nearest whole number) with a sensitivity of 63.6% and a specificity of 100% 
was selected to classify low grade mosaicism. A count of 500 cells should be sufficient to 
rule out <1% mosaicism. However, with a view to applying this in clinical settings, a 
more cautious approach would be to count 1000 cells by FISH (NB: This value would 
be applicable only if the probe used is with 100% efficiency). Analysis of more 
patients (>30) should also be done to use it in the clinical set-up.  
 
Applying this value, none of the controls were classified as low-grade mosaics. In the 
study group I the classification remained the same i.e., 7 out of 11 patients were above 
the cut-off. The other three patients (cases 1, 2 and 8) in this group, who also showed a 
low percentage of monosomy X cells, could not be classified as low-grade mosaics, as 
they did not fall above the set cut-off level. This could be due to the proportions and 
distribution of the two cell lines present in the peripheral blood (Sergey et al., 1999). 
Hence such patients with Turner stigmata necessitate the assessment of karyotypes in 
other tissues, notably the skin (Nazarenko et al., 1999). Therefore, the genetic diagnosis 
in such cases may also require the use of FISH analysis in cells from tissues of different 
germ layers. Another possible reason could be the possible selection that may result in the 
disappearance of cell lines (Procter et al., 1984; Held et al., 1992).  
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The high in-utero lethality of 45,X condition has led to the hypothesis that most of the 
liveborn 45,X individuals have low frequency of mosaicism. Most, if not all, liveborn 
45,X Turner syndrome individuals are mosaic and have some normal cells in some 
tissues or possibly had normal cells in the placenta. Sex chromosomal mosaicism in 
karyotypically proven 45,X Turner patients has been comparatively studied in greater 
detail as opposed to the study group I. With the use of FISH, ‘hidden’ mosaicism has 
been detected in apparently non-mosaic 45,X patients (Held et al., 1992). In one study, it 
was shown that out of 22 Turner patients, 8 had similar results by FISH and karyotyping, 
whereas an additional 5 showed a second 46,XX cell line by FISH (Abulhasan et al., 
1999). In another study, 37 out of 47 Turner patients were classified as having hidden 
mosaicism with the 46,XX cell line by FISH technique (Fernandez-Garcia et al., 2000). 
Similar results were reported, where out of 35 women with a clinical suspicion of Turner 
syndrome, 17 cases (48.6%) showed the same karyotype with FISH and routine 
cytogenetics; in 18 cases (51.4%) a new cell line was identified by FISH (Cortes-
Gutierrez et al., 2003).  
 
In this study Group II, 17 patients who had typical Turner phenotype were analyzed; only 
two patients (cases 8 and 11) had the typical monosomy X karyotype. 15 out of 17 
patients showed 45,X/46,XX mosaicism both with routine G-banding and the FISH 
technique. The percent of normal 46,XX cells ranged from 0.2% to 95% and there was no 
discrepancy in the values between the two techniques. The remaining two patients who 
did not show a second cell line with routine G-banding showed a low percentage of 
normal 46,XX cells ranging from 0.06% to 0.1% with the FISH technique. This 
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percentage of normal cells is relatively low as compared to other studies which show a 
range of 3-18%, with an average of 7% normal cells (Nazarenko et al., 1999). 
 
These two cases remained apparent 45,X with G-banding, which may be explained by 
tissue-confined mosaicism (Held, 1993) or a consequence of a selective loss of a second 
cell line during embryonic development (Held et al., 1992). Tissue-confined mosaicism 
could again point to the necessity of analysis of tissue types other than the blood analysis 
only as in our study.  
 
Another reason could be confined placental mosaicism, which refers to mosaicism that is 
only present in the placenta. The placenta is a very important organ for all mammals. It 
has often been overlooked when studying individuals with Turner syndrome. Careful 
examination of the placenta as well as placental cytogenetic and molecular studies is 
necessary to understand as to what allows individuals with Turner syndrome to survive. 
 
From this study, the FISH technique proves to be a valuable tool in detecting low-grade 
mosaicism in contrast to the routine cytogenetic methods. In some patients, FISH 
application has highlighted the differences between the initial diagnosis based on the 
standard cytogenetic technique and the final diagnosis determined by the application of 
DNA probes specific for the X-chromosomes. Other molecular methods like quantitative 
fluorescent polymerase chain reaction (QF-PCR) have been employed mainly for rapid 
detection of common aneuploidies. This technique consists of DNA amplification by 
polymerase chain reaction (PCR) using fluorescent labeled primers for the analysis of 
 78
chromosome specific small tandem repeats (STR) (Covone et al., 2004). However, the 
molecular detection of sex chromosomal mosaicism is still hindered by the sensitivity of 
QF-PCR to detect low percentages of cell lines with X monosomy. This was first 
demonstrated in a trial performed on blood samples (Cirigliano et al., 1999), which 
showed that mosaics 46,XX (90%)/45,X (10%) are not detectable by the assay and was 
also confirmed on prenatal samples (Schmidt et al., 2000). Once again interphase FISH 
proves to be a better technique in diagnosing low percent mosaicism (~1%) compared to 
QF-PCR. 
  
Another experimental technique in addition to interphase FISH and QF-PCR which has 
been tried is the molecular detection of 45,X Turner patients based on the ability of 
HpaII, a methylation sensitive endonuclease. HpaII induces the cleavage of non-
methylated DNA in the active X-allele. Normal control females or mosaic patients, with a 
second methylated X-chromosome, escape from HpaII digestion, whereas 45,X patients 
who have just one active non-methylated X-chromosome, completely digested by HpaII 
(Longui et al., 2002). However, by means of this technique it is highly impossible to 
detect low grade 46,XX/45,X mosaicism. 
 
Dual-labeled X-chromosome probes were used in the FISH experiments in this study. 
One probe was the FITC-labeled X centromeric probe and the other one was the spectrum 
orange labeled locus-specific Xp terminal probe. This enables the detection of Xp 
deletions very easily, which might be missed with the use of a single X centromeric probe 
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(Figure 13 & Figure 17 A and B). In addition, the Xp terminal probe serves as a good 
internal control. It was noted that some X chromosomes might have split centromeres and 
reflect as two green centromeric signals giving a false impression of two X chromosomes 
(Figure 16 A and B). By using the internal control this error was avoided.  Hence the use 
of both X centromeric as well as Xp terminal probe while scoring for X chromosomes is 
suggested. Cells with FISH signals which could not be reasonably explained were not 
scored in the study (Fig 18). However this was a rare occurrence. 
 
Karyotyping and FISH technique both have their advantages and should ideally be 
carried out together. However, in serially repeated samples, karyotyping need not be 
repeated each time, as the change in percentage of normal and abnormal cells is better 
detected by FISH. The results of FISH are available in two days. The FISH test is thus 
rapidly gaining importance as a useful diagnostic tool, as more probes are now available 











Figure 16: FISH on interphase nuclei showing split centromeres 
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Using a set of control patients and the highly sensitive and  reliable technique of FISH, a 
cut-off level of 1% abnormal cells (on a count of 1000 interphase cells and 100% 
efficient probe) was selected, above which low grade mosaicism can be classified as 
significant. Analysis of more patients should be done before this could be offered as a 
clinical test to patients.  
Using this value, 7 out of 11 patients were classified as low grade mosaics. However, 
with analysis of other additional tissues from a different germ line, a higher sensitivity 
may be achieved. 
Eighty eight percent of  group II  patients (karyotypically proven Turner patients) showed 
normal 46,XX cells, both with G-banding and FISH whereas the remaining 12% showed 
a low percent of 46,XX cells only with FISH technique. No conclusion can be drawn 
regarding the significance of the XX cell line, as this study unfortunately has only two 
samples which are pure 45,X with G-banding. 
 However, standard metaphase analysis if supplemented with additional FISH studies of 
interphase nuclei to screen for the presence of ‘hidden’ mosaicism would enhance the 
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8. Appendix  
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8.1: Appendix 1: 
Colchicine working solution: 
Material: Colchicine (Sigma Cat. No: 9754) 
Method: Dissolve 0.04gms colchicine in 100ml phosphate buffered saline (pH7.2). 
Filter sterilize using 0.22µ filter. Dilute 1:9 to give 0.004% working solution. Store stock 
and working solution at 4°C. 
Phosphate buffered saline: 
Material: pH 6.8 Cat no. 331992P. 
pH 7.2 Cat no.332012W 
Method: Dissolve 1 PBS tablet in 1000ml distilled water. 
Trypsin for banding: 
Material: Difco-Bacto Trypsin (Difco Cat no. 0153-61-6) 
Method: Reconstitute vial with 10ml sterile distilled water. Dissolve 1ml of stock with 




Material: Analar grade Sodium chloride (Sigma Cat no. S-3014). 
Method: Dissolve 9gms NaCl in 1 litre distilled water. 
Hydrogen peroxide: 
Material: H2O2 (Merck Cat no.1.07210.1000). 
Stock solution is 30%. 
Method: Dilute 1:3 with warm tap water for banding pretreatment. 
Leishman’s stain: 
Materials: 
3gms Leishman’s powder (BDH 34042M) 
1000ml absolute methanol 
Method: Dissolve Leishman’s powder in absolute methanol slowly and stir well. Cover 
loosely with plastic film and leave stirring overnight. Filter leishman’s stain with No.1 
Whatman filter paper. 
0.075M potassium chloride(KCl): 
Method: 0.56 gms potassium chloride in 100 ml distilled water. 
20XSSC solution: 
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Mix thoroughly 132g of 20XSSC in 400ml purified water and adjust pH to 5.3 with HCl. 
Add purified water to bring the final volume to 500ml. 
Wash Solution 1(0.4X SSC/0.3% NP-40) for FISH: 
Mix thoroughly 20ml 20XSSC (pH5.3) with 950ml purified water. Add 3ml of NP-40. 
Mix thoroughly until NP-40 is better dissolved. Measure pH and adjust pH to 7.0-7.5 
with NaOH. Add purified water to bring the final volume to 1 litre. 
Wash solution 2 (2XSSC/0.1% NP-40) in FISH: 
Mix thoroughly 100ml of 20XSSC (pH 5.3) with 850ml of purified water. Add 1ml NP-
40. Measure pH and adjust to pH 7.0±0.2 with NaOH. Add purified water to bring the 












8.3: Appendix 3: 
Quality Assurance certificate stating the 100% efficiency (100% sensitive and 100% 
specific) of the probe from Vysis.  
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